Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013


Screening Asia

12 Nov 2013 - 13 Nov 2013 - Singapore



Bookmark and Share


SELECTBIO is pleased to present the 3rd Screening Asia conference, which will take place at the Biopolis, Singapore. Featuring Dr Hakim Djaballah, Director of the HTS Core Facility at Memorial Sloan-Kettering Cancer Center as Conference Chair, this event aims to provide you with an insight into the latest developments in screening technologies and their applications.

During this conference, you will learn about many advances in discovery technologies, including 3D cell-based assays and label free screening, as well as the use of model organisms such as C. Elegans. Focus will also be given to natural product screening and emerging targets. Attending this event will provide you with excellent opportunities for networking with like minded peers, helping you to find solutions and build collaborations.

Running alongside the Screening Asia 2013 conference will be an exhibition covering the latest technological advances and associated services within this field. Registered delegates will also have access to the co-located Lab-on-a-Chip Asia and Genomics Research Asia conference tracks, ensuring a cost effective trip. We look forward to welcoming you to the conference, and hope that the two days will be both informative and enjoyable.

You can  present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 29 October 2013

REGISTER NOW! Our 2for1 offer expires on 30 June 2013.




Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!